IP Library Granted Patent US 12,114,908
Granted Patent B2
US 12,114,908 · App. 17/835,057 · Granted Oct 15, 2024

Methods and apparatus for pumping coolant to an energy delivery device

Inventors: Craig Robert Bockenstedt (Bothell, WA); Gregory T. Wing (Carnation, WA)
Assignee: Solta Medical Ireland Limited
A61B18/02A61B18/1206A61B18/18A61B2018/00452A61B2018/00642A61B2018/00791A61B2018/1253A61B2018/126A61B2018/1266A61B2018/128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,114,908
App. No.
17/835,057
Granted
Oct 15, 2024
Kind
B2
Abstract

Apparatus and methods for delivering coolant to an energy delivery device used to treat tissue with electromagnetic energy. A cooling system includes a pump that is configured to pump a coolant to the energy delivery device.

Claims (39)

1. A method for treating tissue with electromagnetic energy, the method comprising:

heating a fluid inside a container to a selected temperature that provides a pressurized fluid maintained in a liquid state inside the container; and

pumping the pressurized fluid from the container to an energy delivery device configured to emit the electromagnetic energy.

2. The method of claim 1 wherein the pressurized fluid is pumped from the container to the energy delivery device using a diaphragm pump.

3. The method of claim 2 wherein the pressurized fluid is pumped from the container to the energy delivery device using a first line upstream of the diaphragm pump and a second line downstream of the diaphragm pump, the first line is at a first pressure, and the second line is at a second pressure.

4. The method of claim 3 wherein the first pressure is in a range from about 50 psi to about 80 psi, and the second pressure is in a range from about 110 psi to about 130 psi.

5. The method of claim 3 wherein the second pressure is greater than the first pressure.

6. The method of claim 1 wherein the pressurized fluid is pumped from the container to the energy delivery device using a diaphragm pump, the diaphragm pump is coupled to the container by a fluid line, and the pressurized fluid is also maintained under pressure in the liquid state inside the fluid line.

7. The method of claim 1 wherein the pressurized fluid is a coolant.

8. The method of claim 7 wherein the energy delivery device includes an electrode, and further comprising:

delivering a spray of the coolant from a nozzle to the electrode.

9. The method of claim 1 further comprising:

delivering the electromagnetic energy from the energy delivery device to treat the tissue.

10. An apparatus for treating tissue with electromagnetic energy, the apparatus comprising:

an energy delivery device configured to deliver the electromagnetic energy for treating the tissue, the energy delivery device including an electrode, a nozzle, and a control valve;

a first manifold configured to hold a container containing a fluid;

a heater configured to at least partially surround the container;

a cooling system including a pump configured to pump the fluid from the container to the energy delivery device; and

a second manifold arranged between the pump and the control valve, the second manifold including an arrestor configured to respond to pressure surges from operation of the pump,

wherein the pump is a diaphragm pump, and the control valve is configured to control delivery of the fluid from the nozzle to the electrode.

11. The apparatus of claim 10 further comprising:

a system controller communicatively coupled to the energy delivery device and to the cooling system, the system controller programmed to control operation of the heater to heat the fluid inside the container to a selected temperature that provides a pressurized fluid and to control the pump to pump the pressurized fluid from the container to the energy delivery device such that the fluid is maintained in a liquid state inside the container.

12. The apparatus of claim 10 wherein the energy delivery device is configured to emit the electromagnetic energy from the electrode.

13. The apparatus of claim 10 wherein the fluid is a coolant.

14. An apparatus for treating tissue with electromagnetic energy, the apparatus comprising:

an energy delivery device configured to deliver the electromagnetic energy for treating the tissue;

a first manifold configured to hold a container containing a fluid;

a heater configured to at least partially surround the container;

a cooling system including a pump configured to pump the fluid from the container to the energy delivery device;

a first fluid line coupling the first manifold with the pump;

a second manifold coupled to the first manifold by the first fluid line;

a second fluid line coupling the pump to the second manifold;

a first check valve in the first fluid line; and

a second check valve in the second fluid line.

15. The apparatus of claim 14 wherein the second manifold includes an arrestor configured to respond to pressure surges from operation of the pump.

16. The apparatus of claim 14 wherein the second manifold includes one or more relief valves.

17. The apparatus of claim 14 wherein the first manifold includes a pressure sensor, and the pressure sensor is tapped into a fluid path inside the first manifold.

18. The apparatus of claim 14 wherein the fluid is a coolant.

19. The apparatus of claim 14 wherein the pump is a diaphragm pump.

Assignments (12)
U.S. PATENT SECURITY AGREEMENT Recorded Nov 25, 2025
From: SOLTA MEDICAL IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 073715/0394 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 073654/0300 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 24, 2023
From: BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 062853/0655 →
CONFIRMATORY PATENTS ASSIGNMENT Recorded Jan 11, 2023
From: BAUSCH HEALTH IRELAND LIMITED
To: SOLTA MEDICAL IRELAND LIMITED
Reel/Frame 062352/0396 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 062078/0276 →
SECURITY AGREEMENT (SECOND LIEN) Recorded Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
SECURITY AGREEMENT (FIRST LIEN) Recorded Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
SECURITY INTEREST Recorded Sep 16, 2022
From: BAUSCH HEALTH IRELAND LIMITED; SANTARUS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: BARCLAYS BANK PLC
Reel/Frame 061122/0855 →
SECURITY INTEREST Recorded Sep 16, 2022
From: BAUSCH HEALTH IRELAND LIMITED; SANTARUS, INC.; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 061122/0879 →
SECURITY INTEREST Recorded Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Continuity (3)
Continuation 16556616 · Aug 30, 2019
Provisional Application 62725562 · Aug 31, 2018
Related Publication 20220409256A1 · Dec 29, 2022